Correlation of antidepressive agents and the mortality of end-stage renal disease

Chia Jui Tsai, El Wui Loh, Ching Heng Lin, Tung Min Yu, Chin Hong Chan, Tsuo Hung Lan

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Aim: Depression is one of the most common psychological disorders in end-stage renal disease (ESRD) patients and is associated with impaired quality of life and increased mortality and rate of hospitalization. We aimed to examine the contributions of depression and the use of antidepressive agents in the mortality of ESRD patients. Methods: A retrospective observatory study was conducted using the National Health Insurance Research Database in Taiwan. Patients with newly diagnosed as ESRD during the year 2001 to 2007 were collected. A total of 2312 ESRD patients were identified in the database. Statistical analyses were conducted to examine the contributions of depression and exposure of antidepressive agents in mortality rates of ESRD patients. Results: Diagnosis of depression did not influence mortality rate (mortality rate in patients with depression: 26.5%; mortality rate in patients without depression: 26.2%; P= 1.000). Those who had antidepressive agents exposure had significantly higher mortality rate (mortality rate: 32.3%) than those who did not (mortality rate: 24.5%) (P < 0.001). Conclusions: Our findings suggest that (i) the mortality rate of ESRD patients was not affected by the diagnosis of depression, and (ii) exposure of antidepressive agents in ESRD patients was associated with a higher mortality rate. The high mortality rate in ESRD patients exposed to antidepressive agents can be a bias by indication. Equally, a true contribution of the antidepressive agents cannot be ruled out and this needs clarification.

Original languageEnglish
Pages (from-to)390-397
Number of pages8
JournalNephrology
Volume17
Issue number4
DOIs
Publication statusPublished - May 1 2012
Externally publishedYes

Fingerprint

Antidepressive Agents
Chronic Kidney Failure
Mortality
Databases
National Health Programs
Taiwan
Hospitalization
Retrospective Studies
Quality of Life
Psychology

Keywords

  • antidepressive agent
  • end-stage renal disease
  • mortality
  • national health insurance research database

ASJC Scopus subject areas

  • Nephrology

Cite this

Correlation of antidepressive agents and the mortality of end-stage renal disease. / Tsai, Chia Jui; Loh, El Wui; Lin, Ching Heng; Yu, Tung Min; Chan, Chin Hong; Lan, Tsuo Hung.

In: Nephrology, Vol. 17, No. 4, 01.05.2012, p. 390-397.

Research output: Contribution to journalArticle

Tsai, Chia Jui ; Loh, El Wui ; Lin, Ching Heng ; Yu, Tung Min ; Chan, Chin Hong ; Lan, Tsuo Hung. / Correlation of antidepressive agents and the mortality of end-stage renal disease. In: Nephrology. 2012 ; Vol. 17, No. 4. pp. 390-397.
@article{0172824e4b294d0f967557cbd01cb259,
title = "Correlation of antidepressive agents and the mortality of end-stage renal disease",
abstract = "Aim: Depression is one of the most common psychological disorders in end-stage renal disease (ESRD) patients and is associated with impaired quality of life and increased mortality and rate of hospitalization. We aimed to examine the contributions of depression and the use of antidepressive agents in the mortality of ESRD patients. Methods: A retrospective observatory study was conducted using the National Health Insurance Research Database in Taiwan. Patients with newly diagnosed as ESRD during the year 2001 to 2007 were collected. A total of 2312 ESRD patients were identified in the database. Statistical analyses were conducted to examine the contributions of depression and exposure of antidepressive agents in mortality rates of ESRD patients. Results: Diagnosis of depression did not influence mortality rate (mortality rate in patients with depression: 26.5{\%}; mortality rate in patients without depression: 26.2{\%}; P= 1.000). Those who had antidepressive agents exposure had significantly higher mortality rate (mortality rate: 32.3{\%}) than those who did not (mortality rate: 24.5{\%}) (P < 0.001). Conclusions: Our findings suggest that (i) the mortality rate of ESRD patients was not affected by the diagnosis of depression, and (ii) exposure of antidepressive agents in ESRD patients was associated with a higher mortality rate. The high mortality rate in ESRD patients exposed to antidepressive agents can be a bias by indication. Equally, a true contribution of the antidepressive agents cannot be ruled out and this needs clarification.",
keywords = "antidepressive agent, end-stage renal disease, mortality, national health insurance research database",
author = "Tsai, {Chia Jui} and Loh, {El Wui} and Lin, {Ching Heng} and Yu, {Tung Min} and Chan, {Chin Hong} and Lan, {Tsuo Hung}",
year = "2012",
month = "5",
day = "1",
doi = "10.1111/j.1440-1797.2012.01571.x",
language = "English",
volume = "17",
pages = "390--397",
journal = "Nephrology",
issn = "1320-5358",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Correlation of antidepressive agents and the mortality of end-stage renal disease

AU - Tsai, Chia Jui

AU - Loh, El Wui

AU - Lin, Ching Heng

AU - Yu, Tung Min

AU - Chan, Chin Hong

AU - Lan, Tsuo Hung

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Aim: Depression is one of the most common psychological disorders in end-stage renal disease (ESRD) patients and is associated with impaired quality of life and increased mortality and rate of hospitalization. We aimed to examine the contributions of depression and the use of antidepressive agents in the mortality of ESRD patients. Methods: A retrospective observatory study was conducted using the National Health Insurance Research Database in Taiwan. Patients with newly diagnosed as ESRD during the year 2001 to 2007 were collected. A total of 2312 ESRD patients were identified in the database. Statistical analyses were conducted to examine the contributions of depression and exposure of antidepressive agents in mortality rates of ESRD patients. Results: Diagnosis of depression did not influence mortality rate (mortality rate in patients with depression: 26.5%; mortality rate in patients without depression: 26.2%; P= 1.000). Those who had antidepressive agents exposure had significantly higher mortality rate (mortality rate: 32.3%) than those who did not (mortality rate: 24.5%) (P < 0.001). Conclusions: Our findings suggest that (i) the mortality rate of ESRD patients was not affected by the diagnosis of depression, and (ii) exposure of antidepressive agents in ESRD patients was associated with a higher mortality rate. The high mortality rate in ESRD patients exposed to antidepressive agents can be a bias by indication. Equally, a true contribution of the antidepressive agents cannot be ruled out and this needs clarification.

AB - Aim: Depression is one of the most common psychological disorders in end-stage renal disease (ESRD) patients and is associated with impaired quality of life and increased mortality and rate of hospitalization. We aimed to examine the contributions of depression and the use of antidepressive agents in the mortality of ESRD patients. Methods: A retrospective observatory study was conducted using the National Health Insurance Research Database in Taiwan. Patients with newly diagnosed as ESRD during the year 2001 to 2007 were collected. A total of 2312 ESRD patients were identified in the database. Statistical analyses were conducted to examine the contributions of depression and exposure of antidepressive agents in mortality rates of ESRD patients. Results: Diagnosis of depression did not influence mortality rate (mortality rate in patients with depression: 26.5%; mortality rate in patients without depression: 26.2%; P= 1.000). Those who had antidepressive agents exposure had significantly higher mortality rate (mortality rate: 32.3%) than those who did not (mortality rate: 24.5%) (P < 0.001). Conclusions: Our findings suggest that (i) the mortality rate of ESRD patients was not affected by the diagnosis of depression, and (ii) exposure of antidepressive agents in ESRD patients was associated with a higher mortality rate. The high mortality rate in ESRD patients exposed to antidepressive agents can be a bias by indication. Equally, a true contribution of the antidepressive agents cannot be ruled out and this needs clarification.

KW - antidepressive agent

KW - end-stage renal disease

KW - mortality

KW - national health insurance research database

UR - http://www.scopus.com/inward/record.url?scp=84860208310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860208310&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1797.2012.01571.x

DO - 10.1111/j.1440-1797.2012.01571.x

M3 - Article

C2 - 22260522

AN - SCOPUS:84860208310

VL - 17

SP - 390

EP - 397

JO - Nephrology

JF - Nephrology

SN - 1320-5358

IS - 4

ER -